Association of pharmacogenetics with adverse events of fluorouracil/ capecitabine in patients with cancer

Daniel A. King; Robert B. Diasio; M. Wasif Saif

doi:10.1200/OP.20.01072

Association of pharmacogenetics with adverse events of fluorouracil/ capecitabine in patients with cancer

Daniel A. King, Robert B. Diasio, M. Wasif Saif

Pharmacology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	453-454
Number of pages	2
Journal	JCO Oncology Practice
Volume	17
Issue number	1
DOIs	https://doi.org/10.1200/OP.20.01072
State	Published - Jul 1 2021

ASJC Scopus subject areas

Oncology
Health Policy
Oncology(nursing)

Access to Document

10.1200/OP.20.01072

Cite this

@article{b558328072a648c48164fc2e903cdfb8,

title = "Association of pharmacogenetics with adverse events of fluorouracil/ capecitabine in patients with cancer",

author = "King, {Daniel A.} and Diasio, {Robert B.} and Saif, {M. Wasif}",

year = "2021",

month = jul,

day = "1",

doi = "10.1200/OP.20.01072",

language = "English (US)",

volume = "17",

pages = "453--454",

journal = "JCO Oncology Practice",

issn = "2688-1527",

publisher = "American Society of Clinical Oncology",

number = "1",

}

TY - JOUR

T1 - Association of pharmacogenetics with adverse events of fluorouracil/ capecitabine in patients with cancer

AU - King, Daniel A.

AU - Diasio, Robert B.

AU - Saif, M. Wasif

PY - 2021/7/1

Y1 - 2021/7/1

UR - http://www.scopus.com/inward/record.url?scp=85109084649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85109084649&partnerID=8YFLogxK

U2 - 10.1200/OP.20.01072

DO - 10.1200/OP.20.01072

M3 - Letter

C2 - 33793308

AN - SCOPUS:85109084649

SN - 2688-1527

VL - 17

SP - 453

EP - 454

JO - JCO Oncology Practice

JF - JCO Oncology Practice

IS - 1

ER -

Association of pharmacogenetics with adverse events of fluorouracil/ capecitabine in patients with cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this